Evidence map›Paper›PMID 19737878›Full record

ArticleInvestigative ophthalmology & visual science2010

Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice.

Lampros Panagis, Xiujun Zhao, Yongchao Ge, Lizhen Ren, Thomas W Mittag, John Danias

Open access · hybridAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Role of Complement Dysregulation in Glaucoma.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma.Investigative ophthalmology & visual science · 2019
    Article
  13. Article
  14. T-Lymphocyte Subset Distribution and Activity in Patients With Glaucoma.Investigative ophthalmology & visual science · 2019
    Article
  15. Article
  16. Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. The complex role of neuroinflammation in glaucoma.Cold Spring Harbor perspectives in medicine · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lampros PanagisDepartments of Ophthalmology, Mount Sinai School of Medicine, New York, New York, USA. lampros.panagis@downstate.edu
Xiujun Zhao
Yongchao Ge
Lizhen Ren
Thomas W Mittag
John Danias
Ophthalmology Associates (United States) · USNeurology, Inc · US

Funding

Retinal gene expression changes in glaucomaR01EY015224 · NEI · SUNY DOWNSTATE MEDICAL CENTER · PI DANIAS, JOHN · 2004 to 2012
$3.9M
A bovine eye model for steroid-induced glaucomaR03EY016050 · NEI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CANDIA, OSCAR A · 2005 to 2007
$500k
Complement activation in glaucomaR56EY015224 · NEI · SUNY DOWNSTATE MEDICAL CENTER · PI DANIAS, JOHN · 2008 to 2008
$369k
NEI NIH HHS EY0186NEI NIH HHS EY15224NEI NIH HHS EY16050NEI NIH HHS R01 EY015224NEI NIH HHS R03 EY016050NEI NIH HHS R56 EY015224
6 · The paper itself

Abstract

Purpose. To determine whether differences in gene expression occur between areas of focal retinal ganglion cell (RGC) loss and of relative RGC preservation in the DBA/2 mouse retina and whether they can provide insight into the pathophysiology of glaucoma. Methods. Areas of focal RGC loss (judged by lack of Fluorogold labeling; Fluorochrome, Denver, CO), adjacent areas with relative RGC preservation in DBA/2 retina, and Fluorogold-labeled retina from DBA/2(-pe) (pearl) mice were dissected and used for microarray analysis. RT-PCR and immunoblot analysis were used to confirm differential gene expression. Bioinformatic analysis was used to identify gene networks affected in the glaucomatous retina. Results. Microarray analysis identified 372 and 115 gene chip IDs as up- and downregulated, respectively, by 0.5-fold in areas of RGC loss. Differentially expressed genes included those coding for cytoskeletal proteins, enzymes, transport proteins, extracellular matrix (ECM) proteins, and immune response proteins. Several genes were confirmed by RT-PCR. For at least two genes, differential protein expression was verified. Bioinformatics analysis identified multiple affected functional gene networks. Pearl mice appeared to have significantly different gene expression, even when compared with relatively preserved areas of the DBA/2 retina. Conclusions. Regional gene expression changes occur in areas of focal RGC loss in the DBA/2 retina. The genes involved code for proteins with diverse cellular functions. Further investigation is needed to determine the cellular localization of the expression of these genes during the development of spontaneous glaucoma in the DBA/2 mouse and to determine whether some of these gene expression changes are causative or protective of RGC loss.

Indexed as

AnimalsCarrier ProteinsCytoskeletal ProteinsDisease Models, AnimalEnzymesExtracellular Matrix ProteinsFemaleGene ExpressionGene Expression ProfilingGlaucoma, Open-AngleHistocompatibility Antigens Class IIImmunoblottingMiceMice, Inbred DBAMicroarray AnalysisRetinal Ganglion Cells2-hydroxy-4,4'-diamidinostilbene, methanesulfonate saltCarrier ProteinsCytoskeletal ProteinsEnzymesExtracellular Matrix ProteinsHistocompatibility Antigens Class IIStilbamidines

Identifiers

PMID19737878
PMCPMC2868411
OpenAlexW2092891337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.